Brief: Infant Bacterial Therapeutics Q4 Operating Income SEK -37.5 Mln
13/02/2025 07:34
Feb 13 (Reuters) - Infant Bacterial Therapeutics AB
IBTb.ST :
* Q4 OPERATING INCOME SEK -37.5 MILLION VERSUS SEK -45.7
MILLION
YEAR AGO
Source text: ID:nMFN9qQ2mq
Further company coverage: IBTb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln